Ligand validation:4KMU

RFP: RIFAMPICIN

RFP is a Ligand Of Interest in 4KMU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4KMU_RFP_C_1401	20%	9%	0.291	0.898	2.09	2.35	11	28	4	0	100%	1
4KMU_RFP_H_1401	8%	11%	0.358	0.835	2.15	2	10	26	11	0	100%	1
5UAL_RFP_C_3001	46%	11%	0.212	0.948	2.16	2	11	29	7	0	100%	1
5UAC_RFP_C_3001	37%	6%	0.221	0.92	2.49	2.68	21	36	9	0	100%	1
5UAH_RFP_C_3001	18%	11%	0.32	0.908	2.15	2	11	22	4	0	100%	1
5KOX_RFP_A_502	69%	26%	0.109	0.944	1.49	1.48	7	14	3	0	88%	0.8814
5UH6_RFP_C_1201	59%	7%	0.136	0.919	2.69	2.25	12	21	0	0	100%	1
5HV1_RFP_A_902	43%	13%	0.183	0.905	1.75	2.22	12	29	6	0	100%	1
5UHD_RFP_C_1201	42%	7%	0.238	0.958	2.61	2.26	11	21	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.